ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,284Medicare Part D Prescriptions Filled, Including Refills

Rank: 153 out of 890

$786K Total Retail Price of All Prescriptions

Rank: 104 out of 890

318 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

15% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 11,056 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 581 558 1 7
WARFARIN SODIUM 282 279 2 24
RANITIDINE HCL 264 228 3 49
SIMVASTATIN 255 224 4 5
POTASSIUM CHLORIDE 255 244 4 11
ESCITALOPRAM OXALATE 249 219 6 51
DONEPEZIL HCL 245 232 7 30
HYDROCODONE-ACETAMINOPHEN 237 235 S3 8 3
NAMENDA 216 211 9 36
OMEPRAZOLE 216 213 9 8
DIOVAN 215 214 11 33
AMLODIPINE BESYLATE 203 185 12 1
METOPROLOL TARTRATE 200 200 13 15
LISINOPRIL 193 175 14 4
CITALOPRAM HBR 187 186 15 20
LEVOTHYROXINE SODIUM 183 155 16 2
LANTUS 182 168 17 50
CARVEDILOL 180 164 18 22
RISPERIDONE 180 167 18 78
IPRATROPIUM-ALBUTEROL 172 171 20 193
KLOR-CON M20 171 163 21 72
TAMSULOSIN HCL 148 139 22 32
DIGOXIN 134 134 23 65
POLYETHYLENE GLYCOL 3350 124 119 24 67
QUETIAPINE FUMARATE 117 100 25 73
CLOPIDOGREL 115 109 26 28
TRAMADOL HCL 115 102 26 16
NOVOLOG 114 100 28 178
DILTIAZEM 24HR CD 113 102 29 156
METFORMIN HCL 108 89 30 6
FLUTICASONE PROPIONATE 107 94 31 39
GABAPENTIN 105 87 32 12
IPRATROPIUM BROMIDE 103 103 33 249
PANTOPRAZOLE SODIUM 102 88 34 34
HYDROCHLOROTHIAZIDE 99 95 35 9
LIDODERM 95 94 36 227
NEXIUM 95 88 36 14
PLAVIX 94 85 38 42
ALBUTEROL SULFATE 94 94 38 162
NOVOLIN R 92 90 40 153
CLONIDINE HCL 86 81 41 35
MEGESTROL ACETATE 84 84 R 42 92
CIPROFLOXACIN HCL 83 77 43 58
FAMOTIDINE 74 74 44 90
PREDNISONE 74 73 44 47
CARBIDOPA-LEVODOPA 72 72 46 136
EXELON 70 61 47 113
TRAZODONE HCL 70 52 47 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 63 47 76
LEXAPRO 69 53 50 186
CLOZAPINE 66 0 51 279
NYSTATIN 63 58 52 173
CYMBALTA 62 53 53 45
ADVAIR DISKUS 60 50 54 52
OLANZAPINE 60 45 54 145
LEVOFLOXACIN 58 53 56 107
BISOPROLOL FUMARATE 57 34 57 163
PROMETHAZINE HCL 53 46 R 58 104
PRAVASTATIN SODIUM 53 39 58 10
KLOR-CON M10 52 47 60 165
FINASTERIDE 52 49 60 108
AMOX TR-POTASSIUM CLAVULANATE 51 44 62 132
SERTRALINE HCL 50 46 63 26
GENERLAC 50 50 63 330
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.